Your browser doesn't support javascript.
loading
Human erythroid differentiation requires VDAC1-mediated mitochondrial clearance.
Moras, Martina; Hattab, Claude; Gonzalez-Menendez, Pedro; Fader, Claudio M; Dussiot, Michael; Larghero, Jerome; Le Van Kim, Caroline; Kinet, Sandrina; Taylor, Naomi; Lefevre, Sophie D; Ostuni, Mariano A.
Afiliação
  • Moras M; Université de Paris, UMR_S1134, BIGR, Inserm, F-75015 Paris, France; Institut National de Transfusion Sanguine, F-75015 Paris, France; Laboratoire d'Excellence GR-Ex, F-75015, Paris.
  • Hattab C; Université de Paris, UMR_S1134, BIGR, Inserm, F-75015 Paris, France; Institut National de Transfusion Sanguine, F-75015 Paris, France; Laboratoire d'Excellence GR-Ex, F-75015, Paris.
  • Gonzalez-Menendez P; Laboratoire d'Excellence GR-Ex, F-75015, Paris, France; Institut de Génétique Moléculaire de Montpellier, Univ Montpellier, CNRS, Montpellier.
  • Fader CM; Laboratorio de Biología Celular y Molecular, Instituto de Histología y Embriología (IHEM), Universidad Nacional de Cuyo, CONICET, Mendoza, Argentina; Facultad de Odontología, Universidad Nacional de Cuyo, Mendoza.
  • Dussiot M; Laboratoire d'Excellence GR-Ex, F-75015, Paris, France; Université de Paris, UMR_S1163, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implication, Inserm, F-75014 Paris.
  • Larghero J; AP-HP, Hôpital Saint-Louis, Unité de Thérapie cellulaire, Paris.
  • Le Van Kim C; Université de Paris, UMR_S1134, BIGR, Inserm, F-75015 Paris, France; Institut National de Transfusion Sanguine, F-75015 Paris, France; Laboratoire d'Excellence GR-Ex, F-75015, Paris.
  • Kinet S; Laboratoire d'Excellence GR-Ex, F-75015, Paris, France; Institut de Génétique Moléculaire de Montpellier, Univ Montpellier, CNRS, Montpellier.
  • Taylor N; Laboratoire d'Excellence GR-Ex, F-75015, Paris, France; Institut de Génétique Moléculaire de Montpellier, Univ Montpellier, CNRS, Montpellier, France; Pediatric Oncology Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland
  • Lefevre SD; Université de Paris, UMR_S1134, BIGR, Inserm, F-75015 Paris, France; Institut National de Transfusion Sanguine, F-75015 Paris, France; Laboratoire d'Excellence GR-Ex, F-75015, Paris. sophie.lefevre@inserm.fr.
  • Ostuni MA; Université de Paris, UMR_S1134, BIGR, Inserm, F-75015 Paris, France; Institut National de Transfusion Sanguine, F-75015 Paris, France; Laboratoire d'Excellence GR-Ex, F-75015, Paris. mariano.ostuni@inserm.fr.
Haematologica ; 107(1): 167-177, 2022 01 01.
Article em En | MEDLINE | ID: mdl-33406813
ABSTRACT
Erythroblast maturation in mammals is dependent on organelle clearance throughout terminal erythropoiesis. We studied the role of the outer mitochondrial membrane protein voltage-dependent anion channel-1 (VDAC1) in human terminal erythropoiesis. We show that short hairpin (shRNA)-mediated downregulation of VDAC1 accelerates erythroblast maturation. Thereafter, erythroblasts are blocked at the orthochromatic stage, exhibiting a significant decreased level of enucleation, concomitant with an increased cell death. We demonstrate that mitochondria clearance starts at the transition from basophilic to polychromatic erythroblast, and that VDAC1 downregulation induces the mitochondrial retention. In damaged mitochondria from non-erythroid cells, VDAC1 was identified as a target for Parkin-mediated ubiquitination to recruit the phagophore. Here, we showed that VDAC1 is involved in phagophore's membrane recruitment regulating selective mitophagy of still functional mitochondria from human erythroblasts. These findings demonstrate for the first time a crucial role for VDAC1 in human erythroblast terminal differentiation, regulating mitochondria clearance.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mitofagia / Mitocôndrias Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mitofagia / Mitocôndrias Idioma: En Ano de publicação: 2022 Tipo de documento: Article